Central Hemodynamics in Prehypertension: Effect of the β-Adrenergic Antagonist Nebivolol
Article first published online: 26 OCT 2012
© 2012 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 15, Issue 1, pages 69–74, January 2013
How to Cite
Davis, J. T., Pasha, D. N., Khandrika, S., Fung, M. M., Milic, M. and O’Connor, D. T. (2013), Central Hemodynamics in Prehypertension: Effect of the β-Adrenergic Antagonist Nebivolol. The Journal of Clinical Hypertension, 15: 69–74. doi: 10.1111/jch.12031
- Issue published online: 3 JAN 2013
- Article first published online: 26 OCT 2012
- Manuscript received: April 14, 2012; revised: September 6, 2012; accepted: September 10, 2012
Table S1. Comparison of baseline values for nebivolol and placebo arms.
Figure S1. Recruitment flow diagram for the study. Sixty-eight subjects were initially evaluated in order to achieve targeted enrollment and completion of 50 subjects.
|jch12031_sm_FigS1.tiff||1463K||Supporting info item|
|jch12031_sm_TableS1.docx||238K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.